-
Poloxamer 188 has already been tested in humans with sickle cell anaemia and was found to be safe in the short term - 24 hours of use.
BBC: NEWS | Health | Heart drug for muscular dystrophy
-
Early trials have shown promise in treating sickle-cell anaemia, a disease caused by a faulty haemoglobin gene.
ECONOMIST: Monitor
-
It is now known that genetic variability accounts for 25% of susceptibility to the disease, but that variations in the sickle-cell gene contribute to only a fraction of that.
ECONOMIST: Genetics and infectious disease: The germ of an idea | The
-
Of the millions of people with sickle-cell disease in the world, only some 300 have received a bone marrow transplant because of age (doctors won't perform the procedure on patients 16 years and older) and donor-matching problems.
FORBES: Rebooting the Body
-
He cites a 1978 paper that showed a link between the gene behind sickle cell disease and a variation in a section of junk DNA. Jacobson dismisses as poppycock the notion that noncoding DNA was understood back then.
FORBES: Magazine Article
-
Imani, who was a pupil at Fircroft Primary School in Tooting, suffered from sickle cell anaemia and had been given permission by the school for her extended trip to Jamaica.
BBC: Imani Green Jamaica killing: Eight people arrested
-
Variations in the between-gene regions have been linked to sickle cell anemia and diabetes.
FORBES: Magazine Article